Skip to main content

Advertisement

Log in

Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Using MRI, we evaluated the degree of involvement of muscles in the lower extremities of 18 unselected patients with facioscapulohumeral muscular dystrophy (FSHD). Findings were correlated with fragment size of the mutated gene, age, disease duration and muscle power.

Most affected muscles were the hamstrings followed by the tibialis anterior and the medial gastrocnemius. The vastus-, gluteal- and peroneal muscles were the most unaffected, and the psoas muscle did not show evidence of involvement in any of the investigated subjects. Asymmetric involvement was evident in 15% of the investigated muscles on MRI and 6% on manual muscle strength testing. MRI findings in muscle tended to correlate with disease duration (r = 0.49; p < 0.05), but not with gene fragment size or age. MRI disclosed involvement of muscles performing hip flexion and ankle dorsal flexion that could not be detected by manual muscle strength testing. Otherwise, there was a close correlation (≈ r = 0.75; p < 0.0001) between muscle strength and MRI severity score for other muscle groups.

The present study shows that MRI may disclose muscle involvement in FSHD that is not apparent on manual muscle testing, and suggests that MRI of muscle may be an important assessment tool in clinical trials involving patients with FSHD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kilmer DD, Abresch RT, McCrory MA, Carter GT, Fowler WM Jr, Johnson ER, McDonald CM (1995) Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil. 74(5 Suppl):S131–139

    Article  CAS  PubMed  Google Scholar 

  2. Kissel JT (1999) Fascioscapulohumeral dystrophy. Semin Neurol 19:35–43

    Article  CAS  PubMed  Google Scholar 

  3. Kreigbaum E, barthels KM. Biomechanics. A qualitative approach for studying human movement. 4th edn. Allyn and Bacon 1996:pp 595–601

  4. Lamminen AE (1990) Magnetic resonance imaging of primary skeletal muscle diseases: patterns of distribution and severity of involvement. Br J Radiol 63:946–950

    Article  CAS  PubMed  Google Scholar 

  5. Lunt PW, Jardine PE, Koch MC, Maynard J, Osborn M, Williams M, Harper PS, Upadhyaya M (1995) Correlation between fragment size at D4F10S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-fascioscapulohumeral muscular dystrophy (FSHDD). Hum Mol Genet 4:951–958

    CAS  PubMed  Google Scholar 

  6. Medical Research Council. Aids to the investigation of peripheral nerve injuries. London: Her Majesty’s Stationary Office 1976

  7. Olsen DB, Ørngreen MC, Vissing J (2005) Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 64:1064–1066

    PubMed  Google Scholar 

  8. Ozsarlak O, Schepens E, Parizel PM, Van Goethem JW, Vanhoenacker F, De Schepper AM, Martin JJ (2001) Hereditary neuromuscular diseases. EurJ Radiol 40:184–197

    Article  CAS  Google Scholar 

  9. Phoeni J, Betal D, Roberts N, Helliwell TR, Edwards RHT (1996) Objective quantification of muscle and fat in human dystrophic muscle by magnetic resonance image analysis. Muscle Nerve 19:302–310

    Article  Google Scholar 

  10. Ricci E, Galluzzi G, Deidda G, Cacurri S, Colantoni L, Merico B, Piazzo N, Servidei S, Vigneti E, Pasceri V, Silvestri G, Mirabella M, Mangiola F, Tonali P, Felicetti L (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45:751–757

    Article  CAS  PubMed  Google Scholar 

  11. Tawil R, Figlewicz DA, Griggs RC, Weiffenbach B (1998) Fascioscapulohumeral Dystrophy: A distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 43:279–282

    Article  CAS  PubMed  Google Scholar 

  12. Tawil R, Griggs RC. In: Karpati G, Hilton-Jones D, Griggs RC, (eds) Disorders of voluntary muscle; 7th edn. Cambridge University Press, 2001:464–470

  13. Upadhyaya M, Cooper DN (2002) Molecular diagnosis of facioscapulohumeral muscular dystrophy. E pert Rev Mol Diagn 2:160–171

    Article  CAS  Google Scholar 

  14. Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW (1990) Location of the fascioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336:651–653

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Vissing.

Additional information

Received in revised form: 10 March 2006

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olsen, D.B., Gideon, P., Jeppesen, T.D. et al. Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI. J Neurol 253, 1437–1441 (2006). https://doi.org/10.1007/s00415-006-0230-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-0230-z

Keywords

Navigation